Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is excited to announce that it has secured a prime location for its first Saskatchewan retail store in the city of Lloydminster.
Lloydminster has the unusual geographic distinction of straddling the provincial border with neighbouring Alberta. The city is incorporated by both provinces as one city with a single municipal administration. With a total population of over twenty-seven thousand residents, Lloydminster also benefits from high pass-through traffic between the provinces.
The two-thousand square foot space, located on a main road that runs through the heart of the city, is being redesigned from the ground up with a modern look to showcase Beleave’s brands and complete product lines.
The employee onboarding process has already begun and the Company is working with city officials to seek out and identify qualified area residents to staff the store.
Aside from Beleave’s new storefront, the Company plans to take advantage of the online distribution and sales available to provincial retailers, accessing Saskatchewan’s one million residents.
“We started working with provincial and municipal officials months ago and we thank them for a productive working relationship,” said Andrew Wnek, Beleave’s CEO. “We share the vision expressed by the mayor’s office regarding the economic development and success of the city and look forward to being an active and productive member of their community.”
The Company was selected to operate one of the province’s upcoming cannabis retail stores in June, after a two-phase Request for Proposal process that began in March. Cannabis retail stores in the province must be standalone operations, selling only cannabis, cannabis accessories and ancillary items as defined by the Saskatchewan Liquor and Gaming Authority.
The Company plans to open the store in Fall 2018.
ABOUT BELEAVE INC.
Beleave is a biotech company who’s wholly-owned subsidiary Beleave Kannabis Corp. is licensed to cultivate and sell medical cannabis and produce cannabis oils and extracts pursuant to Health Canada’s Access to Cannabis for Medical Purpose Relations. Beleave has developed a network of medical cannabis clinics under the Medi-Green banner and has applied for various patents to broaden its strong research focused foundation.
This news release contains “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). The use of any of the words “plan”, “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and other similar words, or statements that certain events or conditions “may” or “will” occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.
For further information: Investor Relations Contact: Richard Oyelowo, Phone : (416) 712 – 9402, Email : email@example.com; Media Relations Contact : Grant McLeod, SVP, Regulatory Affairs and General Counsel, Phone : (416) 910 – 3401, Email : firstname.lastname@example.org